NXERA PHARMA CO., LTD.

Analyst Reco. Nxera Pharma Co., Ltd.

Equities

4565

JP3431300007

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-22 am EDT			5-day change	1st Jan Change
1,411 ^JPY	-0.14%		-6.00%	-0.70%

Apr. 18	Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May	MT
Apr. 17	Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May	Apr. 17	MT
Jefferies Adjusts Sosei Group’s Price Target to 2,100 Yen From 1,800 Yen, Keeps at Buy	Mar. 12	MT
Jefferies Adjusts Sosei Group's Price Target to 1,800 Yen From 1,700 Yen, Keeps at Buy	Jan. 25	MT
Jefferies Upgrades Sosei to Buy From Hold, Adjusts Price Target to 1,700 Yen From 1,600 Yen	Nov. 30	MT
Jefferies Downgrades Sosei Group Corporation to Underperform From Buy, Adjusts Price Target to 1,800 Yen From 4,200 Yen	23-06-27	MT
Jefferies Adjusts Sosei’s Price Target to 4,200 Yen From 4,000 Yen, Keeps at Buy	23-03-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW